토끼에서 요도카테터 유치기간에 따른 요로감염 정도 및 항생제 투여 효과

김세웅,이지열,김진호,조용현,윤문수 大韓泌尿器科學會 1998 Korean Journal of Urology Vol.39 No.9

Alprazolam함유 poly(D,L-lactic acid) microsphere의 제조 및 평가

용철순,오두만,권미라,박새해 영남대학교 약품개발연구소 1996 영남대학교 약품개발연구소 연구업적집 Vol.6 No.-

Poly(D.L-lactic acid)(PLA) microspheres containing alprazolam(APZ) were prepared by a solvent-emulsion evaporation method and their release patterns were invostigated in vitro. Various batches of microspherss with different size and drug content were obtained by changing the ration of APZ to PLA, PLA concentration in the dispersed phase and stirring rate. Rod-like APZ crystals on microsphere surface, which were released rapidly and could act as a loading dose, were observed with increasing drug content. The release rate was increased with increase in drug contents and decresase in the molecular weight of PLA. The release rate of APZ for long-acting injectable delivery system in vitro, which would aid in predicting in vivo release profile, could be controlled by properly optimizing various factors affecting characteristics of microspheres.

요관에 발생한 원발성 편평상피암

김세웅,이지열,이승주,박왕진,고준성,조용현,윤문수,이교영 大韓泌尿器科學會 2001 Korean Journal of Urology Vol.42 No.8

방광암에서 TaqMan 탐식자를 이용한 실시간 정량적 PCR에 의한 c-erbB2/neu의 증폭 및 과발현

김세웅,정호석,이승주,이지열,조용현,윤문수,박용현 大韓泌尿器科學會 2001 Korean Journal of Urology Vol.42 No.9

최근 3년간 급성 단순 요로감염의 원인균에 따른 항생제 감수성

김세웅,이지열,박왕진,조용현,윤문수 대한감염학회 2000 감염 Vol.32 No.5

국제 태권도 연맹에 관한 고찰

오세용,한창효 한국스포츠리서치 2004 한국 스포츠 리서치 Vol.15 No.3

This research is about creation background of I,T,F,(International Taekwondo Federation) and relationship between I.T.F.(International Taekwondo Federation) and choi hong hi futhermore, unification with W,T,F(World Taekwondo Federation), The conclusion of this research is as follows. First, Choi hong hi is the one who created word of "Taekwondo" and he spread this sports in north korea from the very beginning, Taekwondo was spreaded through out the world from north korea, Until he died in june 15, 2002, he attended various Taekwondo seminars and taught Taekwondo. Second, I,T,F(International Taekwondo Federation) was created based on political background and the first demonstration team was the the leading role of bridge to create I,T.F,(International Taekwondo Federation), As of today, they organize numerous world Taekwondo contests and demonstration teams to advertise Taekwondo to the world. Third, there is a big controversy for the unification of I,T,F,(International Taekwondo Federation) and W,T,F(World Taekwondo Federation)., But these 2 groups should unify within short period of time to make quality and positive growing.

최근 5년간 요로감염의 원인균 및 항생제 감수성

김세웅,임필빈,정웅교,이승주,이지열,조용현,윤문수 대한화학요법학회 2002 대한화학요법학회지 Vol.20 No.3

배경 : 최근 요로감염 원인균에 대한 내성 증가로 항생제 감수성에 변화를 가져와 요로감염 환자에게 경험적 1차 치료를 위한 항생제 선택에 어려움을 주고 있다. 단순 및 복잡성 요로감염으로 진단 받은 환자들을 대상으로 원인균과 그에 따른 항생제의 감수성을 살펴봄으로써 향후 단순 및 복잡성 요로감염에 대한 항생제의 선택에 도움을 받고자 한다. 대상 및 방법 : 1996년 6월부터 2001년 5월까지 요배양 검사상 요로 감염균이 10^5cfu/ml 이상의 집락이 형성된 200명을 대상으로 해부학적 또는 구조적인 장애 유무에 따라 단순 요로감염 및 복잡성 요로 감염으로 나누어 각각의 원인균과 그에 따른 항생제의 감수성을 후향적으로 분석하였다. 결과 : 복잡성 요로감염의 가장 흔한 원인질환은 신경인성 방광이었다. 단순 요로감염의 가장 흔한 원인균은 E. coli (61.35%)였고 복잡성 요로감염에서는 E. coli 이외의 균이 E. coli 보다 더 흔한 원인균이었다(58.9%). 단순 및 복잡성 오료감염 중 그람 양성균에서는 vancomycin, penicillin 이 높은 감수성을 보인 반면 ciprofloxacin, imipenem이 낮은 감수성을 보였고 그람음성균에서는 amikacin, imipenem이 높은 감수성을 보인 반면 ampicillin, bactrim이 낮은 감수성을 보였다. 결론 : 단순 및 복잡성 요로 감염의 주 원인균으로 그람 음성균주 특히, Ecoli에 의한 감염이 많은 비중을 차지하고 있으나 빈도가 점차적으로 감소하는 추세이다. 또한 병원성 감염 및 도뇨관의 장기 유치에 따른 교대균의 증가, 비병원성 세균의 출현 등으로 인한 E. coli 이외의 기타 그람음성균 및 그람양성균의 증가하는 추세이다. 향후 임상에서 요로감염의 일치 치료제로 많이 사용되고 있는 ampicillin과 bactrim 등의 항생제의 감수성이 낮으므로 사용시 필요하다고 사료된다. Backround : The increasing frequency of failure of urinary tract infections (UTIs) may be due to emerging resistance to commonly prescribed antimicrobials. We studied the causative microorganisms and their antibiotic sensitivities in uncomplicated and complicated UTIs. Methods : We analyzed 219 microorganisms and their antibiotic sensitivities of 200 outpatients who had more than 10^5cfu/ml on urine from June 1996 to May 2001 retrospectively. The patients weredivided into 2 groups, uncomplicated UTI group and commplicated UTI group according to with or without underlying disease. Results : The most common underlying disease of complicated UTI was neurogenic bladder. The most common pathogenic microorganism was Escherichia coli (E. coli) (61.35%) in uncomplicated UTI group but in complicated UTI, non-E, coli(58.9%) was more common than E. coli. In uncomplicated and complicated UTI, vancomycin, penicillin showed relatively higher sensitivity of gram positive organisms, while ciprofloxacin, imipenem showed relatively lower sensitivity, and imipenem, amikacin showed relatively higher sensitivity of gram negative organisms, while bactrim, amipicillin showed relatively lower sensitivity. Conclusion : We consider that gram negative microorgansisms, especially E. coli, is the main cause of UTI. But, we should concern about the increase of gram positive organsms and other gram negative organisms besides E. coli. Bactrim, amipicllin which were prescribed empirically in UTIs, showed relatively lower sensitivity. Regarding tom the choice of adequate drug in the treatment of UTI, it is necessary to consider the change of pathologic microorganisms.

코니칼型 大刑消化槽탱크의 鋼壁强度에 대하여 스트레인 게이지法에 의한 實驗的 硏究

吳世旭,辛容建 동아대학교 환경문제연구소 1980 硏究報告 Vol.4 No.1

Recently the large type of steel tank has been widely used in the various industries such as the chemical, petroleum, food, water and sewerage works, pollution treatment facility industry and so on. For the safe, economical and reasonable design of those facilities, engineers have made their efforts, but even by such safety designs, there have happened unanticipated accidents, which have caused not only the damage of life and property but also the death of earth and sea by their pollution. The causes of those accidents have occurred from the problems of design, execution, low cycle fatigue, stress concentration or excessive residual stress, etc. Therefor, even after the complete design, the nondestructive measurement just before a test run after having manufactured the facilities should be necessarily carried out to prevent any accident. This study on the conical type large digester tank built, first in Korea, at the Yongho-dong Sewage Treatment Plant in Busan was dealt with the experimental consideration of its safety by using the strain gauge method, and the results are as the following: 1. The strength of the welded zone in circumferential direction at the shell plate of conical type tank is in safety. 2. By the first hydraulic test result, the maximum stress was brought about at the junction T welded zone in circumferential and axial directions near cone-skirt support bearing. By the second hydraulic test result, the safety strength was obtained more than the calculated values by the preloading effect. 3. The welded zone at the cone-skirt support bearing are under compression stress all in three axies directions, and their strength is in safety.

유전 알고리듬을 이용한 퍼지 규칙 베이스의 자동생성

김용호,심귀보,전홍태,박세희 중앙대학교 생산공학연구소 1992 생산공학연구소 논문집 Vol.1 No.1

Fuzzy logic rule based controller has many desirable advantages, which are simple to implement on the real time and need not the information of structure and dynamic characteristics of the system. Thus, nowadays, the scops of the application of the fuzzy logic controller becomes enlarged. But, if the controlled plant is a time-varying/nonlinear system, it is not easy to construct the fuzzy logic rules which need the knowledge of an expert. In this paper, an approach by which the logic control rules can be auto-generated using the genetic algorithm that is known to be very effective in the optimization problem will be proposed and the effectiveness of the proposed approach will be verified by computer simulation of the 2 d.o.f. planner robot.

요로감염증 환자의 치료에서 메로페넴(Meropenem)과 이미페넴/실라스타틴(Imipenem/Cilastatin)의 임상효과 및 안정성

김세웅,이승주,이지열,조용현,신완식,윤문수 대한화학요법학회 1999 대한화학요법학회지 Vol.17 No.1

목적 :메로페넴은 실라스타틴을 복합투여하지 않아도 되는 새로운 계열의 카바페넴계 항생물질이다. 요로감염 치료에 있어서의 메로페넴의 효과와 안전성을 평가하기 위하여 기존의 카바페넴계 항생물질인 이미페넴/실라스타틴과 동시에 비교임상실험을 실시하였다. 방법 : 본 임상시험은 전향적, 무작위 방법을 통하여 시행하였다. 1996년 10월부터 1998년 2월까지 가톨릭대학교 의과대학 부속 성모병원 및 울산대학교 외과대학 부속 중앙병원 비뇨기과에 입원한 신우신염과 복잡성방광염 환자 115명을 대상으로 하였고, 연속적 무작위 배정방법을 통하여 메로페spa군 58명과 이미페넴/실라스타틴군 57명으로 분류하였다. 두가지 약제는 모두 0.5 g을 12시간 간격으로 정맥주사 하였고, 평균 투약기간은 4일 (3-8일) 이었다. 임상효과, 세균학적 평가 및 부작용을 비교 관찰하였다. 결과 : 총 67명의 환자가 시험을 완료하여 평가가 가능하였고, 이 중 메로페넴군은 34명이었고, 이미페넴/실라스타틴군은 33명이었다. 증상의 치료 및 개선을 임상적 유효성이 있는 경우로 하였을 때, 메로페넴투여군은 34례중 32례 (94.1%)에서, 이미페넴/실라스타틴투여군은 33례중 29례 (87.9%)에서 유효율을 보였다. 세균학적 평가에서 메로페넴 투여군은 34례중 32례 (94.1%)에서, 이미페spa/실라스타틴투여군은 33례중 29례 (87.9%)에서 세균학적 소실율을 보였다. 세균학적 재발 은 각각 4명과 7명이 나타났고, 재감염은 메로페넴군은 나타나지 않았지만, 이미페넴/실라스타틴군은 2명이 나타났다. 임상효과와 세균학적 평가에서는 두 약제간의 통계학적 차이는 없었다. 부작용은 메로페spa투여군 56례중 1례 (1.8%)에서, 이미페넴/실라스타틴투여군 53례중 1례 (1.9%)에서 나타났으며, 임상검사치 이상은 메로페넴투여군 45례중 10례 (22.2%)에서, 이미페넴 실라스타틴투여군 44례중 8례 (18.2%)에서 나타났으나 전체적으로 특별히 문제가 된 증례는 없었다. 결론 :결론적으로 메로페spa은 신우신염 및 복잡성방광염과 같은 요로감염에 대하여 이미페넴/실라스타틴과 동등한 효과를 나타내는 유용한 약제라고 생각된다. Background : Metopenem is the first of a new class carbapenems which may be administered without cilastatin. The clinical study was carried out to assess efficacy and safety of metopenem in the treatment of urinary tract infections, in comparison to imipenem/cilastatin. Methods : This was a controlled, two-center, prospective, randomized study with two parallel groups. From October 1996 until February 1998, a total of 115 consecutive patients with urinary tract infections, such as pyeolonephritis and complicated cystitis, were randomly allocated into two groups, 58 in the meropenem group and 57 in the imipenem/cilastatin group. Both drugs were administered intravenously, at a dose of 0.5 g every 12 hours. The mean duration of therapy was 4 days (3-8 days) for both treatment. Clinical and bacteriological reponses were assessed at the begining of treatment, during treatment, at the end of treatment, and follow-up (1-2 weeks). Results : A total of 67 patients, 34 of meropenem and 33 of imipenem/cilastatin, were evaluable for response. Overall, a positive clinical response (recovery and improvement) was observed in 32 (94.1%) of 34 patients treated with meropenem and in 29 (87.9%) of 33 patients with imipenem/cilastin and the corresponding eradication rates of the primary pathogens were 32 (94.1%) of 34 patients and 29 (87.9%) of 33 patients, respectively. The microbiological relapse after the treatment completion was recorded in 4 patients treated with meropenem and 7 patients given imipenem/cilastath and superinfections occurred in none and 2 patients, respectively. No statistically significant differences in the clinical or bacteriological outcome were observed between the treatment groups. Both drugs were well tolerated with adverse events considered to be related to therapy being recorded for 1 (1.8%) of 56 patients treated with meropenem and 1 (1.9%) of 53 of those who had been given imipenenjcilastatin. Conclusion : Empirial monotherapy with meropenem was therefore as effective and as well tolerated as that with imipenem/cilastatin for the treatment of urinary tract infections.